Form 8.5 (EPT/RI)-Replacement of Dechra

Morgan Stanley & Co. Int'l plc
17 October 2023
 

AMENDMENT(2(b))

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley & Co. International plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

Dechra Pharmaceuticals plc

(c) Name of the party to the offer with which exempt principal trader is connected:

EQT (EQT X EUR SCSp and EQT X USD SCSp)

(d) Date dealing undertaken:

13 October 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

     If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

1p ordinary

PURCHASES

130,647

37.9700 GBP

37.8900 GBP

1p ordinary

SALES

106,439

37.9700 GBP

37.8900 GBP

1p ordinary

SALES

2,824

46.0572 USD

46.0572 USD

 

(b)        Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

1p ordinary

CFD

increasing a long position

80

37.9124 GBP

1p ordinary

CFD

increasing a long position

38

37.9300 GBP

1p ordinary

CFD

increasing a long position

949

37.9400 GBP

1p ordinary

CFD

increasing a long position

425

37.9400 GBP

1p ordinary

CFD

increasing a long position

1,944

37.9435 GBP

1p ordinary

CFD

increasing a short position

892

37.9400 GBP

1p ordinary

CFD

increasing a short position

255

37.9400 GBP

1p ordinary

CFD

increasing a short position

1,712

37.9400 GBP

1p ordinary

CFD

increasing a short position

112

37.9404 GBP

1p ordinary

CFD

increasing a short position

91

37.9411 GBP

1p ordinary

CFD

increasing a short position

2

37.9500 GBP

1p ordinary

CFD

increasing a short position

8,758

37.9507 GBP

1p ordinary

CFD

increasing a short position

20,000

37.9590 GBP

1p ordinary

CFD

increasing a short position

372

37.9600 GBP

1p ordinary

CFD

reducing a long position

425

37.9200 GBP

1p ordinary

CFD

reducing a long position

1,108

37.9407 GBP

1p ordinary

CFD

reducing a long position

51

37.9416 GBP

1p ordinary

CFD

reducing a long position

9,651

37.9444 GBP

1p ordinary

CFD

reducing a short position

1,557

37.9200 GBP

1p ordinary

CFD

reducing a short position

75

37.9200 GBP

1p ordinary

CFD

reducing a short position

956

37.9310 GBP

1p ordinary

CFD

reducing a short position

798

37.9393 GBP

1p ordinary

CFD

reducing a short position

965

37.9393 GBP

1p ordinary

CFD

reducing a short position

549

37.9400 GBP

1p ordinary

CFD

reducing a short position

180

37.9400 GBP

1p ordinary

CFD

reducing a short position

2,824

37.9600 GBP

 

(c)        Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

3.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

Date of disclosure:

17 October 2023

Contact name:

Craig Horsley

Telephone number:

+44 141 245-7736

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings